Generix SA develops SaaS solutions for supply chain ecosystems.
Solid track record with adequate balance sheet.
Share Price & News
How has Generix's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: GENX's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: GENX exceeded the French Software industry which returned 11.9% over the past year.
Return vs Market: GENX exceeded the French Market which returned -6.6% over the past year.
Price Volatility Vs. Market
How volatile is Generix's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StWhat Percentage Of Generix SA (EPA:GENX) Shares Do Insiders Own?
1 month ago | Simply Wall StShould You Think About Buying Generix SA (EPA:GENX) Now?
1 month ago | Simply Wall StOne Generix SA (EPA:GENX) Analyst Just Made A Major Cut To Next Year's Estimates
Is Generix undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: GENX (€6.2) is trading above our estimate of fair value (€3.13)
Significantly Below Fair Value: GENX is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: GENX is good value based on its PE Ratio (24.3x) compared to the Software industry average (30.4x).
PE vs Market: GENX is poor value based on its PE Ratio (24.3x) compared to the French market (14.9x).
Price to Earnings Growth Ratio
PEG Ratio: GENX is poor value based on its PEG Ratio (15.8x)
Price to Book Ratio
PB vs Industry: GENX is overvalued based on its PB Ratio (3.4x) compared to the FR Software industry average (2x).
How is Generix forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GENX's forecast earnings growth (1.5% per year) is above the savings rate (0.6%).
Earnings vs Market: GENX's earnings (1.5% per year) are forecast to grow slower than the French market (13.3% per year).
High Growth Earnings: GENX's earnings are forecast to grow, but not significantly.
Revenue vs Market: GENX's revenue (4.3% per year) is forecast to grow faster than the French market (3.9% per year).
High Growth Revenue: GENX's revenue (4.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GENX's Return on Equity is forecast to be low in 3 years time (10.2%).
How has Generix performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: GENX has high quality earnings.
Growing Profit Margin: GENX's current net profit margins (6.7%) are higher than last year (0.7%).
Past Earnings Growth Analysis
Earnings Trend: GENX's earnings have grown by 0.5% per year over the past 5 years.
Accelerating Growth: GENX's earnings growth over the past year (968.5%) exceeds its 5-year average (0.5% per year).
Earnings vs Industry: GENX earnings growth over the past year (968.5%) exceeded the Software industry -3.8%.
Return on Equity
High ROE: GENX's Return on Equity (12.4%) is considered low.
How is Generix's financial position?
Financial Position Analysis
Short Term Liabilities: GENX's short term assets (€41.6M) exceed its short term liabilities (€40.2M).
Long Term Liabilities: GENX's short term assets (€41.6M) exceed its long term liabilities (€20.4M).
Debt to Equity History and Analysis
Debt Level: GENX's debt to equity ratio (41.8%) is considered high.
Reducing Debt: GENX's debt to equity ratio has increased from 10.2% to 41.8% over the past 5 years.
Debt Coverage: GENX's debt is well covered by operating cash flow (57%).
Interest Coverage: GENX's interest payments on its debt are well covered by EBIT (18.1x coverage).
What is Generix's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate GENX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate GENX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if GENX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if GENX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of GENX's dividend in 3 years as they are not forecast to pay a notable one for the French market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ms. Aïda Collette-Sène has been Chief Executive Officer at Generix SA since October 2018.
CEO Compensation Analysis
Compensation vs Market: Aïda's total compensation ($USD414.18K) is about average for companies of similar size in the French market ($USD434.45K).
Compensation vs Earnings: Insufficient data to compare Aïda's compensation with company performance.
|Chief Executive Officer||1.67yrs||€370.28k||0.099% €137.4k|
|Chairman of Management Board & President||1.67yrs||€442.74k||2.85% €4.0m|
|Chief Financial & Administrative Officer and Member of Management Board||no data||€686.35k||0.22% €310.0k|
|Chief Technical Officer||0.25yr||no data||no data|
|Chief Marketing Officer||0.42yr||no data||no data|
|Chief Sales Officer||0.083yr||no data||no data|
|Chief Customer Services Officer||0.083yr||no data||no data|
Experienced Management: GENX's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.
|Chairman of the Supervisory Board||8.75yrs||€10.00k||1.85% €2.6m|
|Independent Member of Supervisory Board||10.92yrs||€10.00k||no data|
|Independent Member of the Supervisory Board||15.33yrs||€10.00k||no data|
|Vice Chairman of Supervisory Board||14.58yrs||€10.00k||no data|
|Independent Member of the Supervisory Board||11.67yrs||€10.00k||1.39% €1.9m|
|Member of the Supervisory Board||no data||€10.00k||0.0045% €6.2k|
|Member of Supervisory Board||12.58yrs||€10.00k||0.64% €887.8k|
|Member of Supervisory Board||8.75yrs||€10.00k||no data|
Experienced Board: GENX's board of directors are seasoned and experienced ( 11.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Generix SA's company bio, employee growth, exchange listings and data sources
- Name: Generix SA
- Ticker: GENX
- Exchange: ENXTPA
- Founded: 1990
- Industry: Application Software
- Sector: Software
- Market Cap: €138.597m
- Shares outstanding: 22.35m
- Website: https://www.generixgroup.com
Number of Employees
- Generix SA
- ARTEPARC - Bât. A
- 2 rue des Peupliers
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|GENX||ENXTPA (Euronext Paris)||Yes||Ordinary Shares||FR||EUR||Jul 1998|
|0JAW||LSE (London Stock Exchange)||Yes||Ordinary Shares||GB||EUR||Jul 1998|
|GENXP||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Ordinary Shares||GB||EUR||Jul 1998|
Generix SA develops SaaS solutions for supply chain ecosystems. The company's supply chain hub platform offers supply chain execution solutions, including warehouse management software; transport management software to reduce transport costs and associated administrative charges; manufacturing execution system that connects the warehouse to the production floor; enterprise asset management solution for inventory visibility in the field, spare parts management, and asset visibility and tracking; yard management software; and logistics order management system. Its supply chain hub platform also provides B2B integration solutions, such as EDI software, invoice services solution, finance and government services solution, and fax/PDF/OCR solution; and collaboration and visibility solutions comprising supplier, customer, carrier, third-party logistics providers (3PL), and invoice portals, as well as stock replenishment software, and order tracking and supply chain finance solutions. In addition, the company’s supply chain hub platform offers collaborative network; onboarding services, a solution that enables businesses to automate the process of enlisting B2B counterparts; and data lake, a key to analytics and predictive analytics. Further, it provides TradeXpress, a B2B integration software that supports various inter-application modes of mediation, such as EDI, B2B, MFT, ETL, EAI, and ESB, as well as management of regulated flows; and solutions for customer loyalty. The company operates in 50 countries worldwide. It primarily serves manufacturers, 3PL, and retailers. Generix SA was founded in 1990 and is headquartered in Lesquin, France.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/06/03 22:17|
|End of Day Share Price||2020/06/03 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.